Arrowhead Pharmaceuticals Inc. buy B. Riley
Start price
22.01.26
/
50%
€59.50
Target price
22.01.27
€86.40
Performance (%)
-11.03%
Price
02.04.26
€52.94
Summary
This prediction is currently active. The prediction for Arrowhead Pharmaceuticals Inc. disappoints with a performance of -11.03%. This prediction currently runs until 22.01.27. The prediction end date can be changed by B__Riley at any time. B__Riley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Arrowhead Pharmaceuticals Inc. | 0.303% | 0.303% |
| iShares Core DAX® | 2,49 % | -5,94 % |
| iShares Nasdaq 100 | 1,65 % | -2,46 % |
| iShares Nikkei 225® | 0,55 % | -7,60 % |
| iShares S&P 500 | 1,35 % | -2,94 % |
Comments by B__Riley for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals (NASDAQ:ARWR) had its price target raised by analysts at B. Riley from $61.00 to $101.00. They now have a "buy" rating on the stock.
Ratings data for ARWR provided by MarketBeat
Stopped prediction by B__Riley for Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€18.85
14.02.25
14.02.25
€36.16
14.02.26
14.02.26
185.20%
15.02.26
15.02.26
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€21.28
12.08.24
12.08.24
€50.31
12.08.25
12.08.25
-28.88%
13.08.25
13.08.25
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€31.22
20.07.23
20.07.23
€49.32
20.07.24
20.07.24
-17.26%
21.07.24
21.07.24